Search Videos and More

Showing 1 - 12 of 15 results

Previous| 1 | 2 |Next


Transatlantic Exchanges in Immuno-Oncology Video

Transatlantic Exchanges in Immuno-Oncology

Join our transatlantic panel of experts for an interactive, full-day virtual conference to be up to date with all the most exciting discoveries in immuno-oncology!
Care and Innovation: Medical Oncology at Dana-Farber Video

Care and Innovation: Medical Oncology at Dana-Farber

Trace the remarkable growth and development of medical oncology at Dana-Farber — from its early roots to today's mission-driven commitment to excellence in research, care, collaboration, and training.
Cancer FactFinder Website Launched to Provide Fact-Based, Reliable Information About Causes of Cancer News

Cancer FactFinder Website Launched to Provide Fact-Based, Reliable Information About Causes of Cancer

A team led by the Zhu Family Center for Global Cancer Prevention at Harvard T.H. Chan School of Public Health and the Center for Cancer Equity and Engagement at the Dana-Farber/Harvard Cancer Center has launched a new website that provides accurate and reliable information about what does and does not cause cancer.
Dana-Farber Cancer Institute Celebrates 75th Anniversary News

Dana-Farber Cancer Institute Celebrates 75th Anniversary

Dana-Farber Cancer Institute launched a year-long celebration of its 75th anniversary to highlight its history and progress in cancer care and transformative cancer research. In marking the notable anniversary, Dana-Farber seeks to recognize the Institute’s many scientific discoveries, advancements in cancer care for patients, and its extraordinary contributions to eradicating cancer in both children and adults.
Study of Fully Vaccinated Patients with Cancer who had Breakthrough COVID-19 Shows 13% Mortality Rate News

Study of Fully Vaccinated Patients with Cancer who had Breakthrough COVID-19 Shows 13% Mortality Rate

The first study to evaluate the clinical characteristics and outcomes of fully vaccinated patients with cancer who had breakthrough COVID-19 infections indicates they remained at high risk for hospitalization and death.
COVID-19 and Cancer: Breakthrough Infections Video

COVID-19 and Cancer: Breakthrough Infections

New study: Fully vaccinated patients with cancer who had breakthrough COVID-19 infections remained at high risk for hospitalization and death. Dana-Farber's Toni Choueiri, MD, highlights the research.
Study Identifies Factors in Tumors’ Response to Natural Killer Cells News

Study Identifies Factors in Tumors’ Response to Natural Killer Cells

The immune cells known as natural killer (NK) cells are part of the body’s first line of defense against cancer. Many efforts are underway to harness NK cells as a form of cancer immunotherapy, but a critical question in the field remains: Why do some tumors tend to be sensitive to NK cells’ attacks while others are more resistant?
Unraveled Podcast Program

Unraveled

Newsweek Names Dana-Farber #3 in the World for Cancer News

Newsweek Names Dana-Farber #3 in the World for Cancer

Dana-Farber Cancer Institute has been named one of the world’s very best cancer hospitals by Newsweek in its new World’s Best Specialized Hospitals 2022 rankings.
Five Dana-Farber Cancer Institute Faculty Members are Inducted in the 2021 Giants of Cancer Care<sup>®</sup> News

Five Dana-Farber Cancer Institute Faculty Members are Inducted in the 2021 Giants of Cancer Care®

Five Dana-Farber Cancer Institute faculty members are inductees of the 2021 Giants of Cancer Care® program.
Study Reveals Factor That Determines ‘Fate’ of Cancer Cells When Tumor Suppressor Gene Function is Restored News

Study Reveals Factor That Determines ‘Fate’ of Cancer Cells When Tumor Suppressor Gene Function is Restored

Many cancers develop from cells that have a malfunctioning tumor suppressor gene, p53, which normally helps control unchecked cell growth and prevent cancer.
Cancer Screenings Rebounded in Late 2020 After COVID-related Decline, but Racial and Economic Disparities Remain for Some Tests News

Cancer Screenings Rebounded in Late 2020 After COVID-related Decline, but Racial and Economic Disparities Remain for Some Tests

The numbers of cancer screening tests rebounded sharply in the last quarter of 2020, following a dramatic decline in the first months of the COVID-19 pandemic, at one large hospital system in the Northeastern United States. These findings were released in a study published in Cancer Cell. The research also found an increase in racial and socioeconomic disparities among users of some screening tests during the pandemic.

Showing 1 - 12 of 15 results

Previous| 1 | 2 |Next